Chimerix Management
Management criteria checks 2/4
Chimerix's CEO is Mike Andriole, appointed in Aug 2023, has a tenure of less than a year. total yearly compensation is $1.31M, comprised of 40.3% salary and 59.7% bonuses, including company stock and options. directly owns 0.35% of the company’s shares, worth €263.67K. The average tenure of the management team and the board of directors is 2 years and 6.1 years respectively.
Key information
Mike Andriole
Chief executive officer
US$1.3m
Total compensation
| CEO salary percentage | 40.3% |
| CEO tenure | less than a year |
| CEO ownership | 0.4% |
| Management average tenure | 2yrs |
| Board average tenure | 6.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$1m | US$528k | -US$82m |
| Sep 30 2023 | n/a | n/a | -US$85m |
| Jun 30 2023 | n/a | n/a | US$180m |
| Mar 31 2023 | n/a | n/a | US$176m |
| Dec 31 2022 | US$2m | US$455k | US$172m |
| Sep 30 2022 | n/a | n/a | US$154m |
| Jun 30 2022 | n/a | n/a | -US$106m |
| Mar 31 2022 | n/a | n/a | -US$101m |
| Dec 31 2021 | US$2m | US$433k | -US$173m |
| Sep 30 2021 | n/a | n/a | -US$145m |
| Jun 30 2021 | n/a | n/a | -US$138m |
| Mar 31 2021 | n/a | n/a | -US$131m |
| Dec 31 2020 | US$960k | US$420k | -US$44m |
| Sep 30 2020 | n/a | n/a | -US$35m |
| Jun 30 2020 | n/a | n/a | -US$98m |
| Mar 31 2020 | n/a | n/a | -US$105m |
| Dec 31 2019 | US$1m | US$292k | -US$113m |
Compensation vs Market: Mike's total compensation ($USD1.31M) is above average for companies of similar size in the German market ($USD401.52K).
Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.
CEO
Mike Andriole (50 yo)
less than a year
Tenure
US$1,312,421
Compensation
Mr. Michael T. Andriole, also known as Mike, is CEO, President & Director of Chimerix, Inc. since August 01, 2023 and had been the Chief Business Officer of Chimerix, Inc. since April 8, 2019 until August...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | less than a year | US$1.31m | 0.35% $ 263.7k | |
| Chief Medical Officer | 3.8yrs | US$931.79k | 0.044% $ 32.7k | |
| Chief Financial Officer | less than a year | no data | 0.12% $ 93.2k | |
| Chief Operating & Commercial Officer | less than a year | no data | no data | |
| Vice President of Accounting & Finance | 4.8yrs | no data | 0.12% $ 92.3k | |
| Chief Technology Officer | 3.3yrs | no data | no data | |
| Senior VP | 9.6yrs | US$793.85k | 0.15% $ 109.2k | |
| Chief Manufacturing Technology Officer | less than a year | no data | no data |
2.0yrs
Average Tenure
49yo
Average Age
Experienced Management: CXF's management team is not considered experienced ( 2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | less than a year | US$1.31m | 0.35% $ 263.7k | |
| Independent Director | 6.1yrs | US$119.52k | 0.34% $ 258.1k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Lead Independent Director | 19.3yrs | US$144.52k | 0.080% $ 60.5k | |
| Chairman | 5yrs | US$1.52m | 0.37% $ 277.4k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 4.2yrs | US$104.52k | 0% $ 0 | |
| Independent Director | 9.8yrs | US$124.52k | 0.011% $ 8.4k | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Independent Director | 6.1yrs | US$117.02k | 0.039% $ 29.5k |
6.1yrs
Average Tenure
62yo
Average Age
Experienced Board: CXF's board of directors are considered experienced (6.1 years average tenure).